Page 4 of 1424 cards per page

Comparison

Compareanecdotal

Epithalon vs SS-31: Evidence and Safety Compared (2026)

Comparison · Reviewed 2026-06-05

Comparison

Compareanecdotal

Epithalon vs Tamoxifen: Evidence and Safety Compared (2026)

Comparison · Reviewed 2026-06-05

Profile

Profilesanecdotal

Epithalon: Evidence, Side Effects, and Regulatory Status (2026)

Profile · Reviewed 2026-06-05

Stack

Stacksanecdotal

Evening Recovery Stack: Evidence Stack (2026)

Stack · Reviewed 2026-06-05

Brief

Briefsn/a

Evolv Launches Oral Hair Growth Supplement Based on GHK-Cu-Inspired Peptide

Brief · Reviewed 2026-07-03

Lifestyle

Lifestylen/a

Exercise on GLP-1 Guide (2026)

Lifestyle · Reviewed 2026-06-05

Dispatch

Dispatchesn/a

FDA Declares Tirzepatide Shortage Resolved, Narrowing Path for Compounders

Dispatch · Reviewed 2026-06-09

Dispatch

Dispatchesn/a

FDA Declares Tirzepatide Shortage Resolved, Narrowing Path for Compounders

Dispatch · Reviewed 2026-06-12

Dispatch

Dispatchesn/a

FDA Declares Tirzepatide Shortage Resolved, Narrowing Room for Compounded Versions

Dispatch · Reviewed 2026-06-11

Dispatch

Dispatchesn/a

FDA Declares Tirzepatide Shortage Resolved, Tightening Rules for Compounding Pharmacies

Dispatch · Reviewed 2026-06-10

Dispatch

Dispatchesn/a

FDA Declares Tirzepatide Shortage Resolved, Tightening Rules on Compounded Copies

Dispatch · Reviewed 2026-06-15

Dispatch

Dispatchesn/a

FDA Declares Tirzepatide Shortage Resolved, Tightening Rules on Compounded Copies

Dispatch · Reviewed 2026-06-16

Dispatch

Dispatchesn/a

FDA says tirzepatide supply stabilized, clears path for compounding changes

Dispatch · Reviewed 2026-06-08

Brief

Briefsn/a

FDA Signals Broader Regulatory Scrutiny of Peptide Products

Brief · Reviewed 2026-06-22

Regulatory

Regulatoryn/a

FDA Warning Letters Tracker Guide (2026)

Regulatory · Reviewed 2026-06-05

Pillar

Essaysn/a

FDA-Approved Peptide Dosing Protocols: Guide (2026)

Pillar · Reviewed 2026-06-05

Brief

Briefsn/a

Financial Times Publishes Guide to Peptides Marketed for Male Wellness

Brief · Reviewed 2026-07-08

Journey

Journeyn/a

First 90 Days on GLP-1 Guide (2026)

Journey · Reviewed 2026-06-05

Comparison

Compareanecdotal

Follistatin-344 vs CJC/Ipa Blend Guide (2026)

Comparison · Reviewed 2026-06-05

Profile

Profilesanecdotal

Follistatin-344: Evidence, Side Effects, and Regulatory Status (2026)

Profile · Reviewed 2026-06-05

Brief

Briefsn/a

Gelteq Advances Peptide Pipeline With Veterinary and Human Clinical Trials

Brief · Reviewed 2026-06-18

Profile

Profilesmoderate

GHK-Cu (Copper Tripeptide-1): Evidence and Safety (2026)

Profile · Reviewed 2026-06-05

Comparison

Comparemoderate

GHK-Cu vs AHK-Cu: Evidence and Safety Compared (2026)

Comparison · Reviewed 2026-06-05

Comparison

Comparemoderate

GHK-Cu vs BPC-157: Evidence and Safety Compared (2026)

Comparison · Reviewed 2026-06-05